cTnI/CK-MB/Myo:Mainly used as an aid in the diagnosis of myocardial infarction;
D-Dimer:Mainly used as an aid in the diagnosis of disseminated intravascular coagulation;
NT-proBNP:Primarily used as an aid in the diagnosis of heart failure.
Applicable to various sample types of plasma and whole blood
Rapid detection of single reagent (12minutes)
Convenient storage and transportation at room temperature
Successfully obtained in the EU CE access certification.
Clinical significance:
The combined test can effectively help clinicians to quickly determine or rule out diseases that cause acute chest pain with dyspnea, and provide early risk stratification and determination of patients, thus helping doctors to diagnose the condition.
Main clinical applications:
1. Differential diagnosis and risk stratification of acute chest pain;
2. Early auxiliary diagnosis of AMI;
3. Assessment of heart failure conditions;
4.Dynamic detection of disease changes.
Applicable departments:
Emergency Medicine, Cardiology, Cardiac Surgery, ICU, Geriatrics, Infectious Diseases, Physical Examination Center
Sample type:plasma and whole blood
Report time:12min
Reference range:cTnI≤0.3 ng/mL;CK-MB≤5 ng/mL;Myo≤58 ng/mL;D-Dimer<0.5 mg/L;NT-proBNP(under 75 :<300 pg/mL; 75 and over:<450 pg/mL)
Storage:4-30℃,sealed and kept away from light and dry
Validity period:18months
Specifications:25 tests/box,50 tests/box